H. Falk

发表

Hepatic disease among workers at a vinyl chloride polymerization plant.

H. Falk, J. Creech, C. Heath, 1974, JAMA.

Mortality and cancer frequency among military nuclear test (Smoky) participants, 1957 through 1979.

H. Falk, C. Heath, M. Zack, 1983, JAMA.

Mortality and Cancer Frequency Among Military Nuclear Test (Smoky) Participants-Reply

H. Falk, C. Heath, M. Zack, 1984 .

Cancer and birth defects near the Drake Superfund site, Pennsylvania.

J. Logue, H. Falk, L. Budnick, 1984, Archives of environmental health.

Epidemiological Studies

H. Falk, R. Waxweiler, Richard J Waxweiler, 1976, Proceedings of the Royal Society of Medicine.

Distinct Changes in the Expression TAZ are Associated with Normal Cervix and Human Cervical Cancer

A. Smith, H. Falk, H. Tyroler, 2018, Journal of Cancer.

The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.

H. Falk, E. Sullivan, M. Kamb, 1996, Archives of internal medicine.

Clinical epidemiology of toxic-oil syndrome. Manifestations of a New Illness.

E. Kilbourne, H. Falk, C. Heath, 1983, The New England journal of medicine.

Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.

E. Kilbourne, H. Falk, M. Kamb, 1996, The Journal of rheumatology. Supplement.

CONGENITAL MALFORMATIONS AND VINYL CHLORIDE

L. Edmonds, H. Falk, J. Nissim, 1975, The Lancet.

INCIDENCE OF CHILDHOOD LEUKÆMIA

H. Falk, C. Heath, J. Falletta, 1973 .

The eosinophilia-myalgia syndrome: the Los Alamos Conference.

E. Kilbourne, H. Falk, L. Shulman, 1991, The Journal of rheumatology.

Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to Angiosarcomas.

H. Falk, I. Selikoff, P. Berk, 1975, The New England journal of medicine.

The syndrome of unexplained generalized lymphadenopathy in young men in New York City. Is it related to the acquired immune deficiency syndrome?

H. Falk, L. Schonberger, J. Curran, 1984, JAMA.

Eosinophilia-myalgia syndrome: CDC update.

H. Falk, S. Auerbach, 1991, Cleveland Clinic journal of medicine.

Eosinophilia-myalgia syndrome: mortality data from the US national surveillance system.

L. Swygert, H. Falk, S. Auerbach, 1993, The Journal of rheumatology.

Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.

E. Kilbourne, H. Falk, M. Posada de la Paz, 1991 .

Eosinophilia-Myalgia Syndrome: Results of National Surveillance

E. Kilbourne, L. Swygert, H. Falk, 1990 .

Interim guidance on the eosinophilia-myalgia syndrome.

D. E. Nelson, E. Kilbourne, L. Swygert, 1990, Annals of internal medicine.

CHARACTERISTICS OF CASES OF ANGIOSARCOMA OF THE LIVER AMONG VINYL CHLORIDE WORKERS IN THE UNITED STATES

H. Falk, J. Creech, C. Heath, 1975, Annals of the New York Academy of Sciences.

Letter: Congenital malformations and vinyl chloride.

L. Edmonds, H. Falk, J. Nissim, 1975, Lancet.

HEPATIC ANGIOSARCOMA ASSOCIATED WITH ANDROGENIC-ANABOLIC STEROIDS

K. Ishak, H. Falk, H. Popper, 1979, The Lancet.

Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology.

I J Selikoff, H. Falk, I. Selikoff, 1978, The American journal of pathology.

GENETIC RISKS OF VINYL CHLORIDE

H. Falk, J. Wagoner, P. Infante, 1976, The Lancet.

NEOPLASTIC RISK AMONG WORKERS EXPOSED TO VINYL CHLORIDE

H. Falk, J. Wagoner, W. Stringer, 1976, Annals of the New York Academy of Sciences.

Anticarcinogenesis--an alternative.

H. Falk, 1971, Progress in experimental tumor research.

Epidemiology of thorotrast-induced hepatic angiosarcoma in the United States.

K. Ishak, H. Falk, H. Popper, 1979, Environmental research.

Letter: Mortality among vinyl-chloride workers.

H. Falk, C. Heath, J. Wagoner, 1974, Lancet.

Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients.

L. F. Horney, E. Kilbourne, L. Swygert, 1992, JAMA.

Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.

E. Kilbourne, W. Flanders, H. Falk, 1993, American journal of epidemiology.

Survey of advertising for nutritional supplements in health and bodybuilding magazines.

H. Falk, R. Philen, S. Auerbach, 1992, JAMA.

Vinyl chloride-associated liver disease.

H. Falk, J. Creech, P. Watanabe, 1976, Annals of internal medicine.

Evolution of thorotrast-induced hepatic angiosarcomas.

K. Ishak, H. Falk, H. Popper, 1979, Environmental research.

Review of four cases of childhood hepatic angiosarcoma—elevated environmental arsenic exposure in one case

L. Edmonds, H. Falk, C. Heath, 1981, Cancer.

Epidemiology of hepatic angiosarcoma in the United States: 1964-1974.

K. Ishak, H. Falk, G. G. Caldwell, 1981, Environmental health perspectives.

Mortality among military participants at the 1957 PLUMBBOB nuclear weapons test series and from leukemia among participants at the SMOKY test

J. Boice, H. Falk, C. Heath, 2016, Journal of radiological protection : official journal of the Society for Radiological Protection.

Arsenic-related hepatic angiosarcoma.

K. Ishak, H. Falk, G. G. Caldwell, 1981, American journal of industrial medicine.

GENETIC RISKS OF VINYL CHLORIDE

H. Falk, J. Wagoner, P. Infante, 1976, The Lancet.

Mortality among people affected by toxic oil syndrome.

E. Kilbourne, H. Falk, M. Posada de la Paz, 1993, International journal of epidemiology.

Tryptophan Contaminants Associated with Eosinophilia-Myalgia Syndrome

E. Kilbourne, H. Falk, S. Caudill, 1993 .